Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance

NCT06343077 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer Patients on Active Surveillance

Interventions

DRUG: Poly-ICLC intramuscular (IM) injection
DRUG: Poly-ICLC, Intertumoral (IT) injection

Sponsor

Ashutosh Kumar Tewari

Collaborators

[object Object]